Skip to main content
. 2010 May 1;1(3):485–491. doi: 10.3892/etm_00000076

Figure 2.

Figure 2.

Disease-free survival curves after hepatectomy for patients who received or did not receive TACE pre-operatively and who had HCC tumors measuring ≥5 cm in diameter. The pre-operative TACE group showed a more favorable outcome than the non-TACE group (p=0.04).